We are live on
!
Find out more
BHCM
Brevan Howard Capital Management Portfolio holdings
AUM
$11.3B
1-Year Est. Return
35.84%
This Fund
S&P 500
This Quarter
Est. Return
+6.05%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
–
AUM
$9.16B
AUM Growth
-$13.2B
(-59%)
Cap. Flow
-$10.8B
Cap. Flow
% of AUM
-117.92%
Top 10 Holdings %
Top 10 Hldgs %
34.38%
Holding
2,371
New
451
Increased
532
Reduced
695
Closed
657
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTKI
First Trust Small Cap BuyWrite Income ETF
FTKI
|
+$1.07B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$111M |
| 3 |
Walmart Inc
WMT
|
+$84M |
| 4 |
Oracle
ORCL
|
+$58.3M |
| 5 |
Broadcom
AVGO
|
+$57.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$1.77B |
| 2 |
Microsoft
MSFT
|
+$184M |
| 3 |
Meta Platforms (Facebook)
META
|
+$128M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$68.8M |
| 5 |
Comfort Systems
FIX
|
+$42.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.09% |
| 2 | Financials | 7.11% |
| 3 | Healthcare | 5.24% |
| 4 | Communication Services | 5.21% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMSR
1601
Terrestrial Energy
IMSR
$577M
| $161K | ﹤0.01% |
+26,400
| New | +$353K |
|
1602
Neuropace
NPCE
$507M
| $157K | ﹤0.01% |
+10,185
| New | +$136K |
|
|
KW
1603
DELISTED
Kennedy-Wilson Holdings
KW
| $157K | ﹤0.01% |
16,258
-11,500
| -41% | -$103K |
|
1604
Community Health Systems
CYH
$415M
| $157K | ﹤0.01% |
50,374
-24,181
| -32% | -$81.3K |
|
1605
Sabre
SABR
$835M
| $157K | ﹤0.01% |
115,286
-300,965
| -72% | -$518K |
|
1606
Definitive Healthcare
DH
$73.7M
| $155K | ﹤0.01% |
54,034
+3,875
| +8% | +$10.7K |
|
1607
Corbus Pharmaceuticals
CRBP
$183M
| $153K | ﹤0.01% |
+18,795
| New | +$232K |
|
1608
Arcturus Therapeutics
ARCT
$200M
| $151K | ﹤0.01% |
24,680
-3,416
| -12% | -$36.9K |
|
|
DFTX
1609
Definium Therapeutics
DFTX
$5.99B
| $149K | ﹤0.01% |
+11,114
| New | +$138K |
|
1610
Compass
COMP
$9.52B
| $148K | ﹤0.01% |
+13,955
| New | +$127K |
|
1611
Matrix Service
MTRX
$326M
| $147K | ﹤0.01% |
12,600
+700
| +6% | +$8.8K |
|
|
AEVA
1612
Aeva Technologies
AEVA
$1.65B
| $146K | ﹤0.01% |
11,010
-27,584
| -71% | -$393K |
|
1613
Sundial Growers
SNDL
$303M
| $146K | ﹤0.01% |
+88,071
| New | +$177K |
|
1614
Array Technologies
ARRY
$819M
| $146K | ﹤0.01% |
15,781
-43,321
| -73% | -$372K |
|
1615
Mama's Creations
MAMA
$822M
| $144K | ﹤0.01% |
+10,710
| New | +$123K |
|
|
NGD
1616
DELISTED
New Gold Inc
NGD
| $144K | ﹤0.01% |
16,485
-4,437
| -21% | -$33.4K |
|
1617
Bioventus
BVS
$1.17B
| $142K | ﹤0.01% |
+19,110
| New | +$137K |
|
1618
B&G Foods
BGS
$276M
| $142K | ﹤0.01% |
32,977
-133,027
| -80% | -$595K |
|
1619
Avantor
AVTR
$9.29B
| $140K | ﹤0.01% |
12,242
-12,994
| -51% | -$160K |
|
1620
Medifast
MED
$135M
| $140K | ﹤0.01% |
+13,125
| New | +$157K |
|
1621
Integra LifeSciences
IART
$1.33B
| $139K | ﹤0.01% |
11,222
-32,166
| -74% | -$428K |
|
1622
Satellogic
SATL
$819M
| $139K | ﹤0.01% |
+74,509
| New | +$161K |
|
1623
Hertz
HTZ
$756M
| $139K | ﹤0.01% |
+26,979
| New | +$147K |
|
1624
Hope Bancorp
HOPE
$1.79B
| $138K | ﹤0.01% |
+12,600
| New | +$136K |
|
1625
Bausch Health
BHC
$2.37B
| $137K | ﹤0.01% |
+19,740
| New | +$130K |
|
Similar funds
GKIM
DCP
VLKIM
ERSOT
DWM
HTC
BCI
Brevan Howard Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Brevan Howard Capital Management held 2,371 positions worth $9.16B, down 59% from $22.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Brevan Howard Capital Management withdrew a net $10.8B in Q4 2025, closing 657 positions and reducing 695 holdings. Its most notable exit was Insmed, an estimated $42.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 4.4% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Brevan Howard Capital Management opened a new position in First Trust Small Cap BuyWrite Income ETF worth $452M.
- Brevan Howard Capital Management's largest Q4 2025 buy was First Trust Small Cap BuyWrite Income ETF: 57,081,120 shares worth $452M.
- Brevan Howard Capital Management added most to Walmart Inc in Q4 2025, an estimated $84M increase.
- Brevan Howard Capital Management's biggest Q4 2025 reduction was iShares Bitcoin Trust, cutting an estimated $1.77B.
- Brevan Howard Capital Management fully exited Insmed in Q4 2025, selling an estimated $42.3M.
- Brevan Howard Capital Management's ten largest holdings make up 34% of its $9.16B portfolio in Q4 2025.
- Brevan Howard Capital Management opened 451 new positions and closed 657 in Q4 2025.
- Brevan Howard Capital Management's portfolio value fell 59% quarter-over-quarter to $9.16B.
Based on Brevan Howard Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.